Questcor Pharmaceuticals (QCOR +20%) soars after its Q3 blew away estimates late yesterday....

|By:, SA News Editor

Questcor Pharmaceuticals (QCOR +20%) soars after its Q3 blew away estimates late yesterday. Profit jumped 98% on significantly higher shipments of its multiple-sclerosis treatment Acthar. The company says it posted a 174% Y/Y increase in paid prescriptions for the drug during the quarter, and a 54% increase in overall vial shipments.